Aurobindo Pharma Q3 Profit Jumps 8% to Rs 910 Cr on Strong Sales

• Aurobindo Pharma's consolidated net profit rose 8% year-on-year to Rs 910 crore in the December quarter.
• The profit increase was driven by robust sales performance in Europe and the US markets.
• Total revenue from operations for the quarter reached Rs 8,646 crore, up from Rs 7,979 crore in the previous year.
• K Nithyananda Reddy, Vice-Chairman and MD, highlighted steady execution and diversified product portfolio as key drivers.
• The company maintains a focus on operational discipline and sustainable value creation.